• By Real World Health Care Editorial Staff  |  Sep 24, 2025

    New Education Series Designed to Remove Barriers to Mental Health Treatment and Recovery

    This summer, the FDA announced the final steps in eliminating the Clozapine Risk Evaluation and Mitigation Strategy (REMS) regulations by modifying labeling to reflect their February 24, 2025, decision to eliminate the REMS program. Terminating REMS is expected to help patients more easily access clozapine and marks a pivotal moment…more.

    Categories: Behavioral Health
  • By Real World Health Care Editorial Staff  |  Jun 18, 2025

    Assisted Outpatient Treatment Expands Options for People with Severe Mental Illness

    People with severe mental illness (SMI)—severe bipolar disorder, schizophrenia spectrum disorders, and major depression with psychotic features – can be caught in a cycle of repeat hospitalizations, homelessness, and incarcerations. While state psychiatric hospitals provide a critical service for people with SMI, the number of state hospital beds has been…more.

    Categories: Behavioral Health
Chat Avatar